|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!
We wanted you to be aware that FDA-approved Hysingla™ ER (hydrocodone bitartrate) extended-release tablets CII has commercially launched in the U.S.
Please click here to view the press release.
Click here for a CME/CEU activity on Improving Treatment of Atrial Fibrillation and Stoke
Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.
Click here to view our Complimentary Online CME/CEU Webcasts
Click Here to visit the Population Health Management Institute
Ebola leaves ongoing health issues for survivors of the viral disease
The Washington Post
Texas nurse Nina Pham, who was infected with the Ebola virus, says she has had ongoing health problems since being cured, an outcome that experts say is not uncommon for Ebola survivors.
Pham told the Dallas Morning News last month that she has experienced hair loss, body aches and insomnia in the months following her infection. She was diagnosed with the disease in mid-October after treating a patient from Liberia who had Ebola.
A roadmap for how many people could lose their health insurance
The New York Times
So how many people in how many states could be affected by the big Supreme Court case about Obamacare’s insurance subsidies? Good question.
A combination of data problems and legal ambiguities make some basic facts about the case difficult to summarize easily. Last week, news media coverage included widely ranging numbers of people who could lose their insurance and where they live. Here’s why it’s hard to estimate.
Does your health insurance cover alternative medicine?
U.S. News & World Report
About a third of U.S. adults use some form of alternative medicine, and most of them likely pay for it out of their own pocket. Alternative methods — from supplements to acupuncture — are used in preventive care as well as the treatment of chronic and acute conditions, but they often aren’t covered by health insurance.
ACCOUNTABLE CARE ORGANIZATIONS
700 physicians to form ACO in Portland
Becker's Hospital Review
The Portland, Oregon, InterHospital Physicians Association has announced plans to launch a new accountable care organization called Care Connect Northwest. Twelve physician organizations, with approximately 700 primary care physicians and specialists, plan to participate in the new ACO.
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.
Request more information or schedule a personal introduction.
ACOs are learning to use big data
Early adopter accountable care organizations are establishing data warehouses. This is a first step in collecting and analyzing healthcare big data. The move toward integrated care makes big data critical to an ACO’s success. Pathologists and clinical laboratory managers will want to follow the healthcare big data trend because laboratory test results will be a major component of that data.
FDA: NEW TREATMENTS & TECHNOLOGY
FDA approves 1st US biosimilar; hold your breath on cost savings
In a much-anticipated decision, the Food and Drug Administration announced this morning the approval of filgrastim-sndz, the first non-brand, complex biopharmaceutical — or biosimilar — in U.S. pharmaceutical history.
The drug, made by Sandoz, will be sold in the U.S. under the much simpler brand name, Zarxio.
Click Here to visit the Genomics, Biotech & Emerging Medical Technology Institute
Genes from dad used more than genes from mom
Genetic Engineering & Biotechnology News
Although we inherit equal amounts of genetic mutations from our parents — the mutations that make us who we are and not some other person — we actually use more of the DNA that we inherit from our dads. In this context, “use” refers to the expression of genes, specifically, allelic gene variants.
Autism is largely down to genes, twins study suggests
Genetic influences on autism are estimated to be between 74-98 percent, a Medical Research Council study of 258 twins suggests.
The King's College London team said 181 of the teenagers had autism, but the risk was far higher in identical twins where one twin had autism, as they share the same DNA.
23andMe and the promise of anonymous genetic testing
The New York Times
The FDA has allowed 23andMe to market genetic tests for mutations directly to the public. The agency said that, for the most part, so-called carrier tests would no longer need advance approval before being marketed this way. But 23andMe is also offering access to its data for research, opening up questions about privacy and anonymity.
Click Here to visit the Center for Preventive Health and Lifestyle Medicine
'Love hormone' nasal spray could reduce calorie intake in men
Medical News Today
A study has found that a single dose of nasal spray containing the hormone oxytocin led to reduced caloric intake in healthy men. In particular, the synthetic nasal formulation reduced the consumption of fatty foods.
How changing your diet can lower your risk for colon cancer
HealthDay News via CBS News
A vegetarian diet might cut your risk of colorectal cancer by 20 percent, a new study finds.
For fish-eating vegetarians, the protective link was even stronger, researchers said.
Colorectal cancer is the second leading cause of cancer death in the United States.
Click Here to visit the Oncology Institute
More evidence breast cancer and prostate cancer cluster in families
Women with close male relatives with prostate cancer are more likely to be diagnosed with breast cancer, a new study confirms.
These findings, from the large Women's Health Initiative, reinforce the results of a 1994 study in the Journal of the National Cancer Institute, the authors write.
A breakthrough treatment for lung cancer approved
On March 5, a novel way to treat lung cancer won approval from the Food and Drug Administration. The latest drug, Opdivo, has showed promise with other cancers, and is the first to use the immune system to tackle hard-to-treat lung tumors. Here’s what you need to know.
Click Here to visit the Behavioral Health Institute
Facebook aims to be a force for good with suicide prevention tool
By Suzanne Mason
There is no denying that Facebook has become an integrated part of our interactions with social media. We use it to share both the good and the bad of our personal lives. From time to time, the bad can overshadow the good, and these negative thoughts and feelings can spill over into social media posts as a cry for help. Recently, Facebook announced it would be launching a new tool to provide important resources to users if they see an alarming post from a Facebook friend.
Are men more narcissistic than women?
Are men more narcissistic than women? New research at the University of Buffalo School of Management certainly suggests they are, based on an analysis of 30 years of research on gender differences. While previous research has studied narcissism in men and women separately, this reportedly is the first to compare data for men against data for women.
For young people in rural areas, suicide poses a growing threat
Suicide is the third leading cause of death for adolescents and young adults, and those who live in rural areas are especially at risk.
For young people between the ages of 10 and 24, the suicide rates in rural areas are nearly double those of urban areas, according to a study published Monday in JAMA Pediatrics. And that disparity is growing.
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063